| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | May 23, 2025 | Kymera Therapeutics, Inc. | COO | Sell | 42.5 | -2,575 | -3.73% | ✗ | $75.4K |
| Mar 3, 2025 | Mar 3, 2025 | Kymera Therapeutics, Inc. | COO | Sell | 91.3 | +23,617 | 53.45% | ✗ | $42.1K |
| May 23, 2024 | May 23, 2024 | Kymera Therapeutics, Inc. | COO | Sell | 42.5 | -2,575 | -5.51% | ✗ | $90.1K |
| Jan 5, 2009 | Jan 6, 2009 | MADRIGAL PHARMACEUTICALS, INC. | Sr. VP, Pgm Mgmt and Clin Ops | Sell | 18.8 | -4,573 | -22.39% | ✓ | $28.4K |